These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 30358722

  • 1. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB.
    Menopause; 2018 Nov; 25(11):1262-1274. PubMed ID: 30358722
    [Abstract] [Full Text] [Related]

  • 2. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB.
    Menopause; 2007 Nov; 14(3 Pt 1):373-84. PubMed ID: 17438515
    [Abstract] [Full Text] [Related]

  • 3. Effects of oestrogens and progestogens on coronary atherosclerosis and osteoporosis of monkeys.
    Adams MR, Williams JK, Clarkson TB, Jayo MJ.
    Baillieres Clin Obstet Gynaecol; 1991 Dec; 5(4):915-34. PubMed ID: 1822826
    [Abstract] [Full Text] [Related]

  • 4. Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial.
    Mack WJ, Hameed AB, Xiang M, Roy S, Slater CC, Stanczyk FZ, Lobo RA, Liu CR, Liu CH, Hodis HN.
    Atherosclerosis; 2003 May; 168(1):91-8. PubMed ID: 12732391
    [Abstract] [Full Text] [Related]

  • 5. The new conundrum: do estrogens have any cardiovascular benefits?
    Clarkson TB.
    Int J Fertil Womens Med; 2002 May; 47(2):61-8. PubMed ID: 11991432
    [Abstract] [Full Text] [Related]

  • 6. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001 May; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 7. Need for research on estrogen receptor function: importance for postmenopausal hormone therapy and atherosclerosis.
    Meyer MR, Haas E, Barton M.
    Gend Med; 2008 May; 5 Suppl A():S19-33. PubMed ID: 18395680
    [Abstract] [Full Text] [Related]

  • 8. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
    Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP, ELITE Research Group.
    N Engl J Med; 2016 Mar 31; 374(13):1221-31. PubMed ID: 27028912
    [Abstract] [Full Text] [Related]

  • 9. Estrogens, progestins, and coronary heart disease in cynomolgus monkeys.
    Clarkson TB.
    Fertil Steril; 1994 Dec 31; 62(6 Suppl 2):147S-151S. PubMed ID: 7958009
    [Abstract] [Full Text] [Related]

  • 10. Coronary heart disease of females: lessons learned from nonhuman primates.
    Clarkson TB, Mehaffey MH.
    Am J Primatol; 2009 Sep 31; 71(9):785-93. PubMed ID: 19382155
    [Abstract] [Full Text] [Related]

  • 11. Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment.
    Gungor F, Kalelioglu I, Turfanda A.
    Angiology; 2009 Sep 31; 60(3):308-17. PubMed ID: 18505742
    [Abstract] [Full Text] [Related]

  • 12. Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women.
    Christian RC, Harrington S, Edwards WD, Oberg AL, Fitzpatrick LA.
    J Clin Endocrinol Metab; 2002 Mar 31; 87(3):1062-7. PubMed ID: 11889163
    [Abstract] [Full Text] [Related]

  • 13. Cholesterol and atherosclerosis: modulation by oestrogen.
    Barton M.
    Curr Opin Lipidol; 2013 Jun 31; 24(3):214-20. PubMed ID: 23594711
    [Abstract] [Full Text] [Related]

  • 14. Timing of the vascular actions of estrogens in experimental and human studies: why protective early, and not when delayed?
    Lenfant F, Trémollières F, Gourdy P, Arnal JF.
    Maturitas; 2011 Feb 31; 68(2):165-73. PubMed ID: 21167666
    [Abstract] [Full Text] [Related]

  • 15. Reproductive hormones and cardiovascular disease mechanism of action and clinical implications.
    Wagner JD, Kaplan JR, Burkman RT.
    Obstet Gynecol Clin North Am; 2002 Sep 31; 29(3):475-93. PubMed ID: 12353669
    [Abstract] [Full Text] [Related]

  • 16. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
    Contreras I, Parra D.
    Am J Health Syst Pharm; 2000 Nov 01; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
    [Abstract] [Full Text] [Related]

  • 17. Controversies about HRT--lessons from monkey models.
    Clarkson TB, Appt SE.
    Maturitas; 2005 May 16; 51(1):64-74. PubMed ID: 15883111
    [Abstract] [Full Text] [Related]

  • 18. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.
    Hodis HN, Mack WJ, Shoupe D, Azen SP, Stanczyk FZ, Hwang-Levine J, Budoff MJ, Henderson VW.
    Menopause; 2015 Apr 16; 22(4):391-401. PubMed ID: 25380275
    [Abstract] [Full Text] [Related]

  • 19. Beneficial effects of soy supplementation on postmenopausal atherosclerosis are dependent on pretreatment stage of plaque progression.
    Meléndez GC, Register TC, Appt SE, Clarkson TB, Franke AA, Kaplan JR.
    Menopause; 2015 Mar 16; 22(3):289-96. PubMed ID: 25072952
    [Abstract] [Full Text] [Related]

  • 20. Low dose estrogens inhibit coronary artery atherosclerosis in postmenopausal monkeys.
    Appt SE, Clarkson TB, Lees CJ, Anthony MS.
    Maturitas; 2006 Sep 20; 55(2):187-94. PubMed ID: 16574351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.